Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.7.042

ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway  

Sun, Tong (Department of Nuclear Medicine, The first Hospital of China Medical University)
Du, Bulin (Department of Nuclear Medicine, The first Hospital of China Medical University)
Diao, Yao (Department of Nuclear Medicine, The first Hospital of China Medical University)
Li, Xuena (Department of Nuclear Medicine, The first Hospital of China Medical University)
Chen, Song (Department of Nuclear Medicine, The first Hospital of China Medical University)
Li, Yaming (Department of Nuclear Medicine, The first Hospital of China Medical University)
Publication Information
BMB Reports / v.52, no.7, 2019 , pp. 457-462 More about this Journal
Abstract
[18F]Fluorodeoxyglucose (FDG) PET/CT imaging has been widely used in the diagnosis of malignant tumors. ATPase family AAA domain-containing protein 2 (ATAD2) plays important roles in tumor growth, invasion and metastasis. However, the relationship between [18F]FDG accumulation and ATAD2 expression remains largely unknown. This study aimed to investigate the correlation between ATAD2 expression and [18F]FDG uptake in lung adenocarcinoma (LUAD), and elucidate its underlying molecular mechanisms. The results showed that ATAD2 expression was positively correlated with maximum standardized uptake value ($SUV_{max}$), total lesion glycolysis (TLG), glucose transporter type 1 (GLUT1) expression and hexokinase2 (HK2) expression in LUAD tissues. In addition, ATAD2 knockdown significantly inhibited the proliferation, tumorigenicity, migration, [18F]FDG uptake and lactate production of LUAD cells, while, ATAD2 overexpression exhibited the opposite effects. Furthermore, ATAD2 modulated the glycometabolism of LUAD via AKT-GLUT1/HK2 pathway, as assessed using LY294002 (an inhibitor of PI3K/AKT pathway). In summary, to explore the correlation between ATAD2 expression and glycometabolism is expected to bring good news for anti-energy metabolism therapy of cancers.
Keywords
ATAD2; GLUT1; HK2; Lung adenocarcinoma; [18F]FDG accumulation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Siegel RL, Miller KD and Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68, 277-300
2 Coudray N, Moreira AL, Sakellaropoulos T, Fenyo D, Razavian N and Tsirigos A (2018) Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med 24, 1559-1567   DOI
3 Yamasaki T, Nakazaki Y, Yoshida M and Watanabe Y (2011) Roles of conserved arginines in ATP-binding domains of AAA+ chaperone ClpB from Thermus thermophiles. FEBS J 278, 2395-2403   DOI
4 Nouet C, Truan G, Mathieu L and Dujardin G (2009) Functional analysis of yeast bcs1 mutants highlights the role of Bcs1p-specific amino acids in the AAA domain. J Mol Biol 388, 252-261   DOI
5 Zou JX, Revenko AS, Li LB, Gemo AT and Chen HW (2007) ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci U S A 104, 18067-18072   DOI
6 Zheng L, Li T, Zhang Y et al (2015) Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer. Oncol Rep 33, 2337-2344   DOI
7 Fouret R, Laffaire J, Hofman P et al (2012) A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma. Clin Cancer Res 18, 5606-5616   DOI
8 Alvarez JV, Belka GK, Pan T et al (2014) Oncogene pathway activation in mammary tumors dictates [18F]-FDG-PET uptake. Cancer Res 74, 7583-7598   DOI
9 Zhang Y, Sun Y, Li Y et al (2013) ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma. Ann Surg Oncol 20, 577-582   DOI
10 Fan Y, Dickman KG, Zong WX (2010) Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J Biol Chem 285, 7324-7333   DOI
11 Caron C, Lestrat C, Marsal S et al (2010) Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29, 5171-5181   DOI
12 Zhang MJ, Zhang CZ, Du WJ, Yang XZ and Chen ZP (2015) ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker. Clin Transl Oncol 18, 1-6   DOI
13 Wu G, Liu H, He H et al (2014) miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis. BMC Cancer 14, 1-11   DOI
14 Wan WN, Zhang YX, Wang XM et al (2014) ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis. APJCP 15, 2777-2783
15 Shang P, Meng FL, Liu YD and Chen XW (2015) Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis. Tumor Biol 36, 4479-4485   DOI
16 Jadvar H, Alavi A, Gambhir SS (2009) [18F]FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 50, 1820-1827   DOI
17 Cho H, Lee YS, Kim J, Chung JY and Kim JH (2013) Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Invest 31, 607-615   DOI
18 Chae YC and Kim JH (2018) Cancer stem cell metabolism: target for cancer therapy. BMB Rep 51, 319-326   DOI
19 Zhuo B, Li Y, Li Z et al (2015) PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. Biochem Biophys Res Commun 464, 401-406   DOI
20 Wang H, Wang L, Zhang YJ, Wang J, Deng YB and Lin DG (2016) Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int 16, 9   DOI
21 Wahlstrom T and Henriksson MA (2015) Impact of MYC in regulation of tumor cell metabolism. Biochim Biophys Acta 1849, 563-569   DOI
22 Boussouar F, Jamshidikia M, Morozumi Y, Rousseaux S and Khochbin S (2013) Malignant genome reprogramming by ATAD2. Biochim Biophys Acta 1829, 1010-1014   DOI
23 Wu K, Wang W, Chen H, Gao W and Yu C (2019) Insulin promotes proliferation of pancreatic ductal epithelial cells by increasing expression of PLK1 through PI3K/AKT and NF-kB pathway. Biochem Biophys Res Commun 509, 925-930   DOI
24 Tsai JS, Chao CH and Lin LY (2016) Cadmium activates multiple signaling pathways that coordinately stimulate Akt activity to enhance c-Myc mRNA stability. PLoS One 11, e0147011   DOI
25 Hong SY, Yu FX, Luo Y and Hagen T (2016) Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cell Signal 28, 377-383   DOI
26 Stine ZE, Walton ZE, Altman BJ, Hsieh AL and Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5, 1024-1039   DOI
27 Ciro M, Prosperini E, Quarto M et al (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res 69, 8491-8498   DOI